ZA200607118B - Method of preparing low-crystallinity oltipraz or amorphous oltipraz - Google Patents

Method of preparing low-crystallinity oltipraz or amorphous oltipraz

Info

Publication number
ZA200607118B
ZA200607118B ZA200607118A ZA200607118A ZA200607118B ZA 200607118 B ZA200607118 B ZA 200607118B ZA 200607118 A ZA200607118 A ZA 200607118A ZA 200607118 A ZA200607118 A ZA 200607118A ZA 200607118 B ZA200607118 B ZA 200607118B
Authority
ZA
South Africa
Prior art keywords
oltipraz
crystallinity
amorphous
preparing low
preparing
Prior art date
Application number
ZA200607118A
Other languages
English (en)
Inventor
Cho Cheong Weon
Kang Kyoung Rae
Lee Sang Ho
Ku Jeong
Kim Taekrho
Lee Sung Hak
Choi Jae Mook
Cheong Jun Hee
An Tae Kun
Park Hyun Jung
Jeon Eun Kyung
Choi Kwang Do
Lim Jee Woong
Hong Kwang Hee
Hong Hyesuk
Kim Ii Hwan
Kim Tae Hyoung
Choi Nak Hyun
Kim Young Hoon
Yeon Kyu Jeong
Suh Hearan
Jin Hae Tak
Kim Jinwan
Min In Ki
Original Assignee
Cj Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Corp filed Critical Cj Corp
Publication of ZA200607118B publication Critical patent/ZA200607118B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B42—BOOKBINDING; ALBUMS; FILES; SPECIAL PRINTED MATTER
    • B42D—BOOKS; BOOK COVERS; LOOSE LEAVES; PRINTED MATTER CHARACTERISED BY IDENTIFICATION OR SECURITY FEATURES; PRINTED MATTER OF SPECIAL FORMAT OR STYLE NOT OTHERWISE PROVIDED FOR; DEVICES FOR USE THEREWITH AND NOT OTHERWISE PROVIDED FOR; MOVABLE-STRIP WRITING OR READING APPARATUS
    • B42D5/00—Sheets united without binding to form pads or blocks
    • B42D5/04—Calendar blocks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B42—BOOKBINDING; ALBUMS; FILES; SPECIAL PRINTED MATTER
    • B42D—BOOKS; BOOK COVERS; LOOSE LEAVES; PRINTED MATTER CHARACTERISED BY IDENTIFICATION OR SECURITY FEATURES; PRINTED MATTER OF SPECIAL FORMAT OR STYLE NOT OTHERWISE PROVIDED FOR; DEVICES FOR USE THEREWITH AND NOT OTHERWISE PROVIDED FOR; MOVABLE-STRIP WRITING OR READING APPARATUS
    • B42D15/00—Printed matter of special format or style not otherwise provided for
    • B42D15/02—Postcards; Greeting, menu, business or like cards; Letter cards or letter-sheets
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200607118A 2004-01-27 2006-08-25 Method of preparing low-crystallinity oltipraz or amorphous oltipraz ZA200607118B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040005000A KR100629771B1 (ko) 2004-01-27 2004-01-27 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법

Publications (1)

Publication Number Publication Date
ZA200607118B true ZA200607118B (en) 2008-04-30

Family

ID=36950958

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200607118A ZA200607118B (en) 2004-01-27 2006-08-25 Method of preparing low-crystallinity oltipraz or amorphous oltipraz

Country Status (12)

Country Link
US (1) US20050163855A1 (xx)
EP (1) EP1737430A1 (xx)
JP (1) JP2007519714A (xx)
KR (1) KR100629771B1 (xx)
CN (1) CN1921837A (xx)
AU (1) AU2005206063B2 (xx)
BR (1) BRPI0507094A (xx)
CA (1) CA2554588A1 (xx)
NO (1) NO20063571L (xx)
RU (1) RU2342926C2 (xx)
WO (1) WO2005070397A1 (xx)
ZA (1) ZA200607118B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
GB0704718D0 (en) * 2007-03-12 2007-04-18 Prendergast Patrick T Compounds and methods for preventing and treating mucositis
AR065720A1 (es) * 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
FR2918277B1 (fr) * 2007-07-06 2012-10-05 Coretecholding Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
ES2382618T3 (es) * 2008-03-25 2012-06-11 Formac Pharmaceuticals N.V. Método de preparación para dispersiones sólidas
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms
US20160376259A1 (en) 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
WO2018047002A1 (en) * 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
WO2018047013A1 (en) * 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
JP2019531344A (ja) * 2016-09-12 2019-10-31 エスティー アイピー ホールディング エージー ４−メチル−５−（ピラジン−２−イル）−３ｈ−１，２−ジチオール−３−チオンの処方物、ならびにそれらの製造方法及び使用方法
KR20190089851A (ko) * 2016-09-12 2019-07-31 에스티 아이피 홀딩 아게 4-메틸-5-(피라진-2-일)-3h-1,2-디티올-3-티온의 제제, 맛-개질 제제, 및 그의 제조 및 사용 방법
WO2019171174A2 (en) * 2018-03-07 2019-09-12 St Ip Holding Ag Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1851571A (en) * 1930-01-31 1932-03-29 Franklin Dev Corp Means for retarding spinning of automobile transmission gears during gear shifting operation
ES2109377T3 (es) * 1991-12-18 1998-01-16 Warner Lambert Co Proceso para la preparacion de una dispersion solida.
AU2001237768A1 (en) * 2000-03-02 2001-09-12 Sang Geon Kim Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
KR20030067935A (ko) * 2002-02-09 2003-08-19 김상건 올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물
NZ521710A (en) * 2000-04-07 2004-06-25 Sang Geon Kim Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці

Also Published As

Publication number Publication date
JP2007519714A (ja) 2007-07-19
EP1737430A1 (en) 2007-01-03
CN1921837A (zh) 2007-02-28
US20050163855A1 (en) 2005-07-28
KR20050077381A (ko) 2005-08-02
RU2006130733A (ru) 2008-03-10
KR100629771B1 (ko) 2006-09-28
AU2005206063B2 (en) 2008-10-02
AU2005206063A2 (en) 2005-08-04
CA2554588A1 (en) 2005-08-04
AU2005206063A1 (en) 2005-08-04
WO2005070397A1 (en) 2005-08-04
NO20063571L (no) 2006-10-19
BRPI0507094A (pt) 2007-06-19
RU2342926C2 (ru) 2009-01-10

Similar Documents

Publication Publication Date Title
ZA200607118B (en) Method of preparing low-crystallinity oltipraz or amorphous oltipraz
IL191990A0 (en) Methods of using cd40 binding agents
ZA200704202B (en) Method for preparing n-phenylpyrazole-1-carboxamides
PL1761510T3 (pl) Sposób wytwarzania 4-(benzimidazolilometyloamino)-benzamidyn
ZA200610204B (en) Irinotecan preparation
ZA200801854B (en) Method of preparing esomeprazole and salts thereof
ZA200805297B (en) Method of using ß-hydroxy-ß-methylbutyrate
RS51808B2 (sr) Postupci za primenu kompozicija aminopiridina sa produženim oslobađanjem
TWI367859B (en) Single crystalline diamond and producing method thereof
EP1773339A4 (en) CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE
EP1764416A4 (en) PROCESS FOR THE MANUFACTURE OF THEANIN
EP2155709A4 (en) STABLE ANHYDROUS CRYSTALLINE DOCETAXEL AND PROCESS FOR PREPARING THE SAME
IL177071A0 (en) Method of preparing a nicotine transdermal preparation
EP1964538A4 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
SG119251A1 (en) Methods
GB0416694D0 (en) Process for preparing microcrystals
PT1858851E (pt) Método de preparação para lercanidipina amorfa
GB0501008D0 (en) Method of producing conjugate vaccines
GB0403629D0 (en) Methods
GB0423552D0 (en) Methods
GB0408228D0 (en) Golf aid
IL180870A0 (en) Method for preparing n-aminopiperedine and its salts
GB0415757D0 (en) Methods
GB0406275D0 (en) Modification of seed
GB0423353D0 (en) Methods of printing